SCHEMBL2750010

SCHEMBL2750010

Cc1ccc(CCCSc2ncccc2C(=O)NCc2cccs2)cc1C(F)(F)F

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.58
▸ KMT2A Q03164 3/20 0.55
▸ LMNA P02545 3/20 0.55
▸ HPGD P15428 5/20 0.49
▸ MAPT P10636 4/20 0.49
▸ MEN1 O00255 2/20 0.49
▸ GLA P06280 1/20 0.49
▸ CYP1A2 P05177 2/20 0.47
▸ CYP3A4 P08684 2/20 0.47
▸ CYP2C9 P11712 2/20 0.47
▸ CYP2C19 P33261 2/20 0.47
▸ CYP2D6 P10635 1/20 0.47
▸ NPSR1 Q6W5P4 1/20 0.47
▸ KDM4E B2RXH2 1/20 0.46
▸ OPRK1 P41145 7/20 0.45
▸ TP53 P04637 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2751546 0.86 ALDH1A1 (0.62) ALDH1A1KMT2ALMNAHPGDMAPT
SCHEMBL2751209 0.85 KMT2A (0.59) ALDH1A1KMT2ALMNAHPGDMAPT
SCHEMBL2750871 0.85 ALDH1A1 (0.67) ALDH1A1KMT2ALMNAHPGDMAPT
SCHEMBL2750057 0.85 ALDH1A1 (0.64) ALDH1A1KMT2ALMNAHPGDMAPT
SCHEMBL2751786 0.83 ALDH1A1 (0.64) ALDH1A1KMT2ALMNAHPGDMAPT
SCHEMBL2750245 0.83 ALDH1A1 (0.61) ALDH1A1KMT2ALMNAHPGDMAPT
SCHEMBL2749474 0.82 ALDH1A1 (0.67) ALDH1A1KMT2ALMNAHPGDMAPT
SCHEMBL2750390 0.82 ALDH1A1 (0.67) ALDH1A1KMT2ALMNAHPGDMAPT
SCHEMBL2750043 0.82 ALDH1A1 (0.60) ALDH1A1KMT2ALMNAHPGDMAPT
SCHEMBL2751542 0.82 ALDH1A1 (0.72) ALDH1A1KMT2ALMNAHPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2406226-B1 SUBSTITUTED NICOTINAMIDES AS KCNQ2/3 MODULATORS GRUENENTHAL GMBH (DE) 2015-09-16 — — EP claimed
US-8586755-B2 Substituted nicotinamides as KCNQ2/3 modulators Grünenthal GmbH (DE) 2013-11-19 — — US claimed
US-20120184550-A1 SUBSTITUTED NICOTINAMIDES AS KCNQ2/3 MODULATORS GRUNENTHAL GMBH (DE) 2012-07-19 — — US claimed
US-8178684-B2 Substituted nicotinamides as KCNQ2/3 modulators GRUENENTHAL GMBH (DE) 2012-05-15 — — US claimed
US-20100234429-A1 SUBSTITUTED NICOTINAMIDES AS KCNQ2/3 MODULATORS Grünenthal GmbH (DE) 2010-09-16 — — US claimed
US-8586755-B2 Substituted nicotinamides as KCNQ2/3 modulators Grünenthal GmbH (DE) 2013-11-19 — — US disclosed
US-20120184550-A1 SUBSTITUTED NICOTINAMIDES AS KCNQ2/3 MODULATORS GRUNENTHAL GMBH (DE) 2012-07-19 — — US disclosed
US-8178684-B2 Substituted nicotinamides as KCNQ2/3 modulators GRUENENTHAL GMBH (DE) 2012-05-15 — — US disclosed
US-20100234429-A1 SUBSTITUTED NICOTINAMIDES AS KCNQ2/3 MODULATORS Grünenthal GmbH (DE) 2010-09-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120184550-A1 SUBSTITUTED NICOTINAMIDES AS KCNQ2/3 MODULATORS KCNQ2, KCNQ1, KCNQ3 ALDH1A1 2196/4885KMT2A 254/4885LMNA 1001/4885
US-20100234429-A1 SUBSTITUTED NICOTINAMIDES AS KCNQ2/3 MODULATORS KCNQ1, KCNQ2, KCNQ3 ALDH1A1 3206/4885KMT2A 422/4885LMNA 461/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback